Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Catalyst Pharmaceuticals (NASDAQ:CPRX) Coverage Initiated by Analysts at Bank of America themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $17.11, but opened at $14.58. Catalyst Pharmaceuticals shares last traded at $14.81, with a volume of 1,673,229 shares. Analyst Ratings Changes CPRX has been the topic of a number of research […]
Catalyst Pharmaceuticals (NASDAQ:CPRX) Rating Reiterated by HC Wainwright modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
O Neil Global Advisors Inc. lifted its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 18.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,343 shares of the biopharmaceutical company’s stock after purchasing an additional 4,505 shares during the period. […]